Serpin A1

Serpin A1

Serpin A1 분자 정보

Molecule Name
Alpha-1-antiproteinase
분자 별명
SerpinA1,PI,A1A,AAT,PI1,A1AT,MGC9222,PRO2275,MGC23330,alpha1AT,SPAAT
Drug Development Progress
임상 약물 수14
시판 약물 수2
최고 연구 개발 단계Approved
표적 별명
Alpha-1-antiproteinase,PRO2209,Serpin Family A Member 1,alpha 1-Antitrypsin,Protease Inhibitor 1 (Anti-Elastase), Alpha-1-Antitrypsin,Alpha-1 Protease Inhibitor,Serpin A1,AAT,PI,Serpin Peptidase Inhibitor Clade A (Alpha-1antiproteinase, Antitrypsin) Member 1,Serine (Or Cysteine) Proteinase Inhibitor, Clade A, Member 1,Alpha-1-Antitrypsin Short Transcript Variant 1C4,Serpin Peptidase Inhibitor Clade A Member 1,Alpha-1-Antitrypsin Null,Alpha-1 Antitrypsin,Alpha-1-Antitrypsin,Alpha1AT,PRO2275,NNIF,A1A,PI1,Epididymis Secretory Sperm Binding Protein,Serpin Peptidase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 1,Serine (Or Cysteine) Proteinase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 1,Alpha-1-Antitrypsin Short Transcript Variant 1C5,A1AT,PRO0684,SPAAT,SERPINA1
분자 배경
Serpin A1 is also known as Alpha-1-antitrypsin (A1AT), serum trypsin inhibitor, alpha-1 proteinase inhibitor (A1PI), AAT, which belongs to the serpin family. Most serpins inactivate enzymes by binding to them covalently, requiring very high levels to perform their function. Like all serine protease inhibitors, A1AT has a characteristic secondary structure of beta sheets and alpha helices. Serpin A1 / A1AT is inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form of SerpinA1 inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin. Serpin A1 / A1AT protects tissues from enzymes of inflammatory cells, especially neutrophil elastase. Defects in SERPINA1 are the cause of alpha-1-antitrypsin deficiency (A1ATD).

Serpin A1 제품 목록

Species
  • Human(1)
Tag
  • His Tag(1)
Host
  • HEK293(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
Serpin A1
Human Serpin A1 Protein, His Tag
Human
HEK293
SDS-PAGE

$290.00

50ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
FazirsiranTAK-999; ADS-001; ARO-AATPhase 3 ClinicalArrowhead Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd
alpha 1-Antitrypsin Deficiency; Hepatic Insufficiency
상세
YOLT-202YOLT-202Phase 3 ClinicalShanghai Yaotang Biotechnology Co Ltd
alpha 1-Antitrypsin Deficiency; Genetic Diseases, Inborn
상세
Efdoralprin alfaINBRX-101; AT-292; rhAAT-Fc; AAT-IgG-Fc; AAT-Fc; SAR447537; SAR-447537Phase 2 ClinicalArecor Ltd, Inhibrx
alpha 1-Antitrypsin Deficiency; Emphysema
상세
TSRA-196TSRA-196Phase 2 ClinicalTessera Therapeutics Inc
alpha 1-Antitrypsin Deficiency
상세
VX-864VX-864Phase 2 ClinicalVertex Pharmaceuticals Incorporated
alpha 1-Antitrypsin Deficiency
상세
KRRO-110KRRO-110Phase 2 ClinicalKorro Bio Inc
alpha 1-Antitrypsin Deficiency
상세
WVE-006WVE-006; GSK-5462688Phase 2 ClinicalWave Life Sciences Ltd
alpha 1-Antitrypsin Deficiency
상세
BEAM-302α1-AD; α-1-AD; BEAM-302Phase 2 ClinicalBeam Therapeutics Inc
alpha 1-Antitrypsin Deficiency
상세
adeno-associated virus gene therapy (University of Massachusetts/University of Florida/NHLBI)Phase 1 ClinicalUniversity of Massachusetts
alpha 1-Antitrypsin Deficiency
상세
KB-408KB-408Phase 1 ClinicalKrystal Biotech Inc
alpha 1-Antitrypsin Deficiency
상세
VX-668VX-668; VX668Phase 1 ClinicalVertex Pharmaceuticals Incorporated
alpha 1-Antitrypsin Deficiency
상세
VX-634VX-634Phase 1 ClinicalVertex Pharmaceuticals Incorporated
alpha 1-Antitrypsin Deficiency
상세
BMN-349BMN-349Phase 1 ClinicalBiomarin Pharmaceutical Inc
alpha 1-Antitrypsin Deficiency
상세
Alpha-1 antitrypsin (Kalytera Therapeutics)ClinicalClalit Health Services
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Alpha1-proteinase inhibitor (Human, Grifols)TAL-6004ApprovedBayer AG, Grifols SaProlastin, Prolastin-cUnited Statesalpha 1-Antitrypsin Deficiencynull1987-12-02
alpha 1-Antitrypsin Deficiency; Coronavirus Disease 2019 (COVID-19); Cystic Fibrosis; Pancreatitis, Chronic; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema
상세
Alfalastin (LFB SA)ApprovedLfb Biotechnologies SasAlfalastinFrancealpha 1-Antitrypsin DeficiencyLfb Biotechnologies Sas2005-08-01
alpha 1-Antitrypsin Deficiency
상세
Customer Reviews